DK0831775T3 - Ophthalmiske emulsioner med langvarig frigivelse - Google Patents

Ophthalmiske emulsioner med langvarig frigivelse

Info

Publication number
DK0831775T3
DK0831775T3 DK96920588T DK96920588T DK0831775T3 DK 0831775 T3 DK0831775 T3 DK 0831775T3 DK 96920588 T DK96920588 T DK 96920588T DK 96920588 T DK96920588 T DK 96920588T DK 0831775 T3 DK0831775 T3 DK 0831775T3
Authority
DK
Denmark
Prior art keywords
long
emulsions
dispersed phase
release ophthalmic
ophthalmic emulsions
Prior art date
Application number
DK96920588T
Other languages
Danish (da)
English (en)
Inventor
M Bowman Lyle
A Patel Rajesh
B Ottoboni Thomas
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of DK0831775T3 publication Critical patent/DK0831775T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK96920588T 1995-06-07 1996-05-29 Ophthalmiske emulsioner med langvarig frigivelse DK0831775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/488,675 US5767153A (en) 1995-06-07 1995-06-07 Sustained release emulsions
PCT/US1996/008119 WO1996040051A1 (en) 1995-06-07 1996-05-29 Sustained release ophthalmic emulsions

Publications (1)

Publication Number Publication Date
DK0831775T3 true DK0831775T3 (da) 2002-10-07

Family

ID=23940673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96920588T DK0831775T3 (da) 1995-06-07 1996-05-29 Ophthalmiske emulsioner med langvarig frigivelse

Country Status (7)

Country Link
US (2) US5767153A (de)
EP (1) EP0831775B1 (de)
AT (1) ATE223698T1 (de)
AU (1) AU5884996A (de)
DE (1) DE69623619D1 (de)
DK (1) DK0831775T3 (de)
WO (1) WO1996040051A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
WO1999016471A1 (fr) 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. Compositions d'emulsions de type aqueux
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US7141607B1 (en) * 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
WO2005018646A1 (ja) * 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
ATE442146T1 (de) 2003-11-07 2009-09-15 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
WO2007068086A1 (en) * 2005-12-05 2007-06-21 Bioartificial Gel Technologies Inc. Emulsion-containing medical articles
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
US20080171790A1 (en) * 2007-01-12 2008-07-17 Filiberto Palmiro Zadini Fatty acids-systemic lipid solubilizers conjugates
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
EP2389939A1 (de) 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
WO1994005298A1 (en) * 1992-08-28 1994-03-17 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery

Also Published As

Publication number Publication date
US5977171A (en) 1999-11-02
ATE223698T1 (de) 2002-09-15
DE69623619D1 (de) 2002-10-17
WO1996040051A1 (en) 1996-12-19
EP0831775B1 (de) 2002-09-11
EP0831775A1 (de) 1998-04-01
AU5884996A (en) 1996-12-30
US5767153A (en) 1998-06-16

Similar Documents

Publication Publication Date Title
DK0831775T3 (da) Ophthalmiske emulsioner med langvarig frigivelse
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
ATE283031T1 (de) Nichtirritierende kosmetische und pharmazeutische zusammensetzungen
ATE192332T1 (de) Alkalische ophthalmische suspensionen
ATE220541T1 (de) Feste wirkstoff-zubereitungen
DE59608732D1 (de) Lagerstabile arzneiformen
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
DK0607118T3 (da) System til administrering af phospholipid
BR9713414A (pt) Processo para a preparação de uma dispersão de polìmero.
DE69524772D1 (de) Ophthalmologisches abgabesystem
ATE264348T1 (de) Bioadhesive zusammensetzungen aus polymeren
DK0744938T3 (da) Flydende oftalmisk afgivelsessystem med vedholdende afgivelse
NO167360C (no) Tverrbundede, poroese polymerer for regulert legemiddelavgivning.
IT1282353B1 (it) Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
SE442997B (sv) Forfarande utgorande av forfarandet enligt krav 1 i se,b, 432 770 varvid till den homogeniserade blandningen en oljeloslig polymerisationsinitiator tillsettes, vilken har en vattenloslighet som medger att den kan diffun
BR9607967A (pt) Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
ES523586A0 (es) "metodo de preparacion de una composicion contraceptiva para administracion vaginal"
ES2080031T1 (es) Preparacion oftalmologica.
BR0109481A (pt) Sistema iniciador estável
DE69733268D1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
BR9802816A (pt) Misturas de dispersão de colóides como colóide de proteção para a polimerização por emulsão aquosa, processo para sua prepação e seu emprego
ATE194489T1 (de) Bioerodierbares system zur kontrollierten freigabe
BR9910305A (pt) Vacina
NZ331051A (en) Instant release forms of gelled active substances